Boeing <BA.N> shares fell 1.2% premarket, eyeing their lowest
open since August, as the crisis around its grounded aircraft
forced it into its biggest assembly-line halt in more than two
decades.
The news soured the mood after three straight days of record
highs for U.S. stock indexes, spurred by cooling trade tensions
between the world's top two economies and upbeat economic data
from China.
The S&P 500 <.SPX> has gained over 27% so far this year, rising
in nine of the last 10 weeks, on expectations of a U.S.-China
trade deal, a dovish Federal Reserve, a strong corporate
earnings season and upbeat economic indicators.
An interim trade agreement was announced on Friday, but some
investors still held off on big bets amid skepticism about the
lack of details. The three index futures were trading slightly
off record levels on Tuesday.
At 7:23 a.m. ET, Dow e-minis <1YMcv1> were down 35 points, or
0.12%, while S&P 500 e-minis <EScv1> were down 1.5 points, or
0.05%. Nasdaq 100 e-minis <NQcv1> were down just 1.25 points,
nearly flat.
Pfizer Inc <PFE.N> rose 1.1% after the U.S. Food and Drug
Administration approved the U.S. drugmaker and Astellas Pharma
Inc's <4503.T> prostate cancer therapy.
Johnson & Johnson <JNJ.N> gained 1.3% after reports that Morgan
Stanley upgraded the stock to "overweight" from "equal weight".
Investor attention now turns to industrial production data for
November, due at 09:15 a.m. ET, to gauge the health of the U.S.
economy, which has so far been resilient despite trade tensions.
(Reporting by Uday Sampath in Bengaluru; Editing by Shounak
Dasgupta)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|